Literature DB >> 19389837

Regulation and function of tissue inhibitor of metalloproteinase (TIMP) 1 and TIMP3 in periovulatory rat granulosa cells.

Feixue Li1, Thomas E Curry.   

Abstract

In the ovary, the matrix metalloproteinases (MMPs) and the tissue inhibitors of metalloproteinase (TIMPs) have been postulated to regulate extracellular matrix remodeling associated with ovulation. In the present study, we investigated the regulatory mechanisms controlling expression of Timp1 and Timp3 mRNA in periovulatory granulosa cells. Granulosa cells were isolated from immature pregnant mare serum gonadotropin-primed (10 IU) rat ovaries and treated with human chorionic gonadotropin (hCG; 1 IU/ml). At 4 h after hCG treatment, Timp1 expression was highest and then decreased gradually over the remaining 24 h of culture. In contrast, hCG induced a biphasic increase of Timp3 expression at 2 and 16 h. The hCG stimulated expression of Timp1 and Timp3 mRNA was blocked by inhibitors of the protein kinase A (H89), protein kinase C (GF109203), and MAPK (SB2035850) pathways. To further explore Timp1 and Timp3 regulation, cells were cultured with the progesterone receptor antagonist RU486, which blocked the hCG induction of Timp3 expression, whereas the epidermal growth factor receptor tyrosine kinase inhibitor AG1478 blocked the hCG stimulation of both Timp1 and Timp3 expression. The prostaglandin-endoperoxide synthase 2 inhibitor NS-398 had no effect. The potential function of TIMP3 was investigated with Timp3-specific small interfering RNA treatment. Timp3 small interfering RNA resulted in a 20% decrease in hCG-induced progesterone levels and microarray analysis revealed an increase in cytochrome P450 Cyp 17, ubiquitin conjugating enzyme E2T, and heat shock protein 70. IGF binding protein 5, stearyl-CoA desaturase, and annexin A1 were decreased. The differential regulation between Timp1 and Timp3 may correlate with their unique roles in the processes of ovulation and luteinization. For TIMP3, this may include regulating fatty acid synthesis, steroidogenesis, and protein turnover.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19389837      PMCID: PMC2717866          DOI: 10.1210/en.2008-1141

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  59 in total

1.  EGF-like growth factors as mediators of LH action in the ovulatory follicle.

Authors:  Jy-Young Park; You-Qiang Su; Miyako Ariga; Evelyn Law; S-L Catherine Jin; Marco Conti
Journal:  Science       Date:  2004-01-15       Impact factor: 47.728

2.  Tissue inhibitor of metalloproteinases-3 induces apoptosis in melanoma cells by stabilization of death receptors.

Authors:  Matti Ahonen; Minna Poukkula; Andrew H Baker; Masahide Kashiwagi; Hideaki Nagase; John E Eriksson; Veli-Matti Kähäri
Journal:  Oncogene       Date:  2003-04-10       Impact factor: 9.867

3.  Tissue inhibitor of metalloproteinase-3 is associated with neuronal death in reperfusion injury.

Authors:  James A Wallace; Susan Alexander; Eduardo Y Estrada; Curt Hines; Lee Anna Cunningham; Gary A Rosenberg
Journal:  J Cereb Blood Flow Metab       Date:  2002-11       Impact factor: 6.200

4.  A null mutation for tissue inhibitor of metalloproteinases-3 (Timp-3) impairs murine bronchiole branching morphogenesis.

Authors:  Sean E Gill; M Cynthia Pape; Rama Khokha; Andrew J Watson; Kevin J Leco
Journal:  Dev Biol       Date:  2003-09-15       Impact factor: 3.582

5.  TIMP-3 mRNA is not overexpressed in Sorsby fundus dystrophy.

Authors:  Ngai Hang Victor Chong; Anders Kvanta; Stefan Seregard; Alan C Bird; Philip J Luthert; Bjorn Steen
Journal:  Am J Ophthalmol       Date:  2003-11       Impact factor: 5.258

6.  Novel signal transduction pathway for luteinizing hormone and its interaction with insulin: activation of Janus kinase/signal transducer and activator of transcription and phosphoinositol 3-kinase/Akt pathways.

Authors:  Carla R O Carvalho; José B C Carvalheira; Maria H M Lima; Suzana F Zimmerman; Luciana C Caperuto; Angélica Amanso; Alessandra L Gasparetti; Vainer Meneghetti; Leonardo F Zimmerman; Licio A Velloso; Mario J A Saad
Journal:  Endocrinology       Date:  2003-02       Impact factor: 4.736

7.  Acute signaling by the LH receptor is independent of protein kinase C activation.

Authors:  Lisa M Salvador; Evelyn Maizels; Dale Buchanan Hales; Eishichi Miyamoto; Hideyuki Yamamoto; Mary Hunzicker-Dunn
Journal:  Endocrinology       Date:  2002-08       Impact factor: 4.736

Review 8.  The matrix metalloproteinase system: changes, regulation, and impact throughout the ovarian and uterine reproductive cycle.

Authors:  Thomas E Curry; Kevin G Osteen
Journal:  Endocr Rev       Date:  2003-08       Impact factor: 19.871

9.  A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2.

Authors:  Jian Hua Qi; Quteba Ebrahem; Nina Moore; Gillian Murphy; Lena Claesson-Welsh; Mark Bond; Andrew Baker; Bela Anand-Apte
Journal:  Nat Med       Date:  2003-03-24       Impact factor: 53.440

10.  Processing and localization of ADAMTS-1 and proteolytic cleavage of versican during cumulus matrix expansion and ovulation.

Authors:  Darryl L Russell; Kari M H Doyle; Scott A Ochsner; John D Sandy; JoAnne S Richards
Journal:  J Biol Chem       Date:  2003-08-07       Impact factor: 5.157

View more
  13 in total

1.  TIMP1 contributes to ovarian anomalies in both an MMP-dependent and -independent manner in a rat model.

Authors:  Julie A W Stilley; Kathy L Sharpe-Timms
Journal:  Biol Reprod       Date:  2012-02-29       Impact factor: 4.285

2.  Induction of Tissue Factor Pathway Inhibitor 2 by hCG Regulates Periovulatory Gene Expression and Plasmin Activity.

Authors:  Muraly Puttabyatappa; Linah F Al-Alem; Farnosh Zakerkish; Katherine L Rosewell; Mats Brännström; Thomas E Curry
Journal:  Endocrinology       Date:  2017-01-01       Impact factor: 4.736

3.  Developmental Programming: Contribution of Epigenetic Enzymes to Antral Follicular Defects in the Sheep Model of PCOS.

Authors:  Xingzi Guo; Muraly Puttabyatappa; Robert C Thompson; Vasantha Padmanabhan
Journal:  Endocrinology       Date:  2019-10-01       Impact factor: 4.736

4.  A role for nuclear factor interleukin-3 (NFIL3), a critical transcriptional repressor, in down-regulation of periovulatory gene expression.

Authors:  Feixue Li; Jing Liu; Misung Jo; Thomas E Curry
Journal:  Mol Endocrinol       Date:  2011-01-06

5.  Ovarian expression, localization, and function of tissue inhibitor of metalloproteinase 3 (TIMP3) during the periovulatory period of the human menstrual cycle.

Authors:  Katherine L Rosewell; Feixue Li; Muraly Puttabyatappa; James W Akin; Mats Brännström; Thomas E Curry
Journal:  Biol Reprod       Date:  2013-11-21       Impact factor: 4.285

6.  Matrix metalloproteinase inhibition influences aspects of photoperiod stimulated ovarian recrudescence in Siberian hamsters.

Authors:  Asha Shahed; Jamie J Simmons; Sydney L Featherstone; Kelly A Young
Journal:  Gen Comp Endocrinol       Date:  2015-04-21       Impact factor: 2.822

7.  Epidermal growth factor receptor (EGFR) signaling is a key mediator of hormone-induced leukocyte infiltration in the pubertal female mammary gland.

Authors:  Mark D Aupperlee; Yong Zhao; Ying Siow Tan; Jeffrey R Leipprandt; Jessica Bennett; Sandra Z Haslam; Richard C Schwartz
Journal:  Endocrinology       Date:  2014-04-02       Impact factor: 4.736

8.  Differential effects of the immunosuppressive calcineurin inhibitors cyclosporine-A and tacrolimus on ovulation in a murine model.

Authors:  F Zakerkish; M J Soriano; E Novella-Mestre; M Brännström; C Díaz-García
Journal:  Hum Reprod Open       Date:  2021-05-11

9.  Hormonal induction of polo-like kinases (Plks) and impact of Plk2 on cell cycle progression in the rat ovary.

Authors:  Feixue Li; Misung Jo; Thomas E Curry; Jing Liu
Journal:  PLoS One       Date:  2012-08-01       Impact factor: 3.240

10.  Extracellular regulated kinase 1/2 signaling is a critical regulator of interleukin-1β-mediated astrocyte tissue inhibitor of metalloproteinase-1 expression.

Authors:  Jerel Fields; Irma E Cisneros; Kathleen Borgmann; Anuja Ghorpade
Journal:  PLoS One       Date:  2013-02-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.